Global X Genomics & Biotechnology ETF
GNOM
GNOM
54 hedge funds and large institutions have $121M invested in Global X Genomics & Biotechnology ETF in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+9
Holders Change %
+20%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
18
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
JFA
51
JNBA Financial Advisors
Bloomington,
Minnesota
| $6K | – | – | – |
|
|
GWM
52
Geneos Wealth Management
Englewood,
Colorado
| $4K | +$4K | +50 | New |
|
53
Bank of Montreal
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
|
PA
54
Parallel Advisors
San Francisco,
California
| $2K | – | – | – |
|
|
T
55
TRUADVICE
Sarasota,
Florida
| – | -$3.65M | -41,261 | Closed |
|
|
FTUS
56
Flow Traders U.S.
New York
| – | -$1.05M | -10,579 | Closed |
|
|
SPC
57
Sigma Planning Corp
Ann Arbor,
Michigan
| – | -$455K | -4,574 | Closed |
|
|
PWM
58
PRW Wealth Management
Quincy,
Massachusetts
| – | -$230K | -2,310 | Closed |
|
59
Barclays
London,
United Kingdom
| – | -$100K | -1,000 | Closed |
|